CUAMC
CAMP icon

China Universal Asset Management Company’s CAMP4 Therapeutics CAMP Stock Holding History

China Universal Asset Management Company’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.5K Sell
800
-15,200
-95% -$65.5K ﹤0.01% 510
2026
Q1 		$70.6K Buy
16,000
+6,000
+60% +$28.5K 0.01% 439
2025
Q4 		$61.3K Buy
+10,000
New +$42.5K ﹤0.01% 442

Other funds holding CAMP

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
PWA
Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

China Universal Asset Management Company's CAMP Position: Q2 2026 in Review

China Universal Asset Management Company reduced its CAMP4 Therapeutics (CAMP) stake by 95% in Q2 2026, selling an estimated $65.5K and leaving 800 shares worth $3.5K. The position accounts for ﹤0.01% of the portfolio, ranked #510.

China Universal Asset Management Company first reported a position in CAMP in Q4 2025 and has held it in 3 quarters since. The position peaked at $70.6K in Q1 2026. 6 funds tracked by Wall St. Rank hold CAMP as of Q2 2026.

  • China Universal Asset Management Company held 800 shares of CAMP4 Therapeutics worth $3.5K as of Q2 2026.
  • China Universal Asset Management Company sold 15,200 CAMP4 Therapeutics shares in Q2 2026, an estimated $65.5K.
  • CAMP4 Therapeutics made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #510 holding.
  • China Universal Asset Management Company first reported a position in CAMP4 Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • China Universal Asset Management Company's CAMP4 Therapeutics position peaked at $70.6K in Q1 2026.
  • 6 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.